This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-report: Archive
CIEN Falls 15.2% in a Week as AI Growth Faces Persistent Supply Risks
by Shreya Majumder
Ciena's 15.2% weekly slide contrasts with surging earnings and AI demand as supply, concentration and valuation risks put execution in focus.
CIENNegative Net Change CSCONegative Net Change LITENegative Net Change
artificial-intelligence business-services cloud-computing communications earnings-outlook earnings-report stock-price-change stock-price-movement tech-stocks
Ciena's 2027 Growth Guide Raises the Stakes for AI Optical Demand
by Shreya Majumder
Ciena targets at least 30% fiscal 2027 revenue growth as AI networking demand builds, with backlog topping $10B expected despite supply constraints.
CIENNegative Net Change CSCONegative Net Change LITENegative Net Change
artificial-intelligence business-services cloud-computing communications earnings-report growth-stocks guidance momentum-stocks revenue tech-stocks
Is Ciena a Buy as 30% Growth Meets Its Premium Forward Valuation?
by Shreya Majumder
Ciena targets at least 30% fiscal 2027 revenue growth as AI demand rises, but its premium valuation, supply risks and cloud concentration raise the stakes.
CIENNegative Net Change CSCONegative Net Change HPENegative Net Change
artificial-intelligence business-services cloud-computing communications computers earnings-report earnings-trend tech-stocks top-ranked trending-stocks valuation
Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ALLONo Net Change RCKTPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Coherent (COHR) Down 10.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Coherent (COHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
COHRNegative Net Change DAVEPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Cerebras (CBRS) Down 17.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cerebras (CBRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CBRSNegative Net Change DUOLPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
by Zacks Equity Research
Altimmune (ALT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ALTPositive Net Change UTHRPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Brinker International (EAT) Down 10% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Brinker International (EAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
EATPositive Net Change CMGPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Cisco (CSCO) Down 5.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cisco (CSCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CSCONegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Red Robin (RRGB) Down 23.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Red Robin (RRGB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RRGBNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate